查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298024

感染控制市场、份额、规模、趋势、行业分析报告：按类型、最终用途、按地区、细分市场预测，2023-2032 年

Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type; End-use; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球感染控制市场预计将达到4008.1亿美元。 该研究报告提供了对当前市场动态的详细见解，并对未来市场增长进行了分析。

需要严格感染控制措施的外科手术的增加是市场的主要驱动力。 据信，感染控制所提供的良好治疗效果是其高适口性的原因。 由于医院和诊所、製药和医疗器械行业对灭菌和消毒的需求增加，COVID-19 大流行对市场增长产生了积极影响。

根据世界卫生组织关于预防医院感染的实用建议，因手术感染而导致的额外住院时间估计约为8天。 住院时间的延长预计将导致住院费用大幅增加，使得临床上实施感染预防措施变得更加紧迫。 对于医院和医疗保健支付者来说，较长的住院时间预计会降低成本效益，因为他们使用过多的资源来治疗获得性感染。

全球感染控制市场竞争激烈且较为分散。 市场进入者正专注于新产品发布、产品开发和全球增长，以提高其市场份额。 该市场的主要参与者包括 Fortive（高级灭菌产品）、3M 公司、Getinge AB、Steris PLC 和 Cantel Medical Corporation。

肺炎、血流感染、尿路感染、手术部位感染、MRSA是医院感染的主要原因。 其他重要的医院获得性感染 (HAIs) 包括导管相关血流、导管相关尿路感染和呼吸机相关肺炎。 HAI 是全球范围内阻碍患者康復并显着增加死亡率的主要问题之一。

感染控制市场报告要点

医院将在 2022 年占据最大的收入份额，并预计在整个预测期内以最快的复合年增长率 (CAGR) 增长。 传染病比例高的主要原因是医院场所感染呼吸道和血源性病原体的风险较高。

2022 年，北美地区的行业份额处于领先地位。 该细分市场市场份额的增加可能是主要市场进入者之间持续建立战略联盟以增强其产品供应和感染控制能力的结果。 北美的主导市场份额也是由于现有企业为在该地区建立自己的地位而做出的更大努力。

内容

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球感染控制市场洞察

  • 感染控制市场 - 行业概况
  • 感染控制市场动态
    • 驱动因素和机遇
      • 需要彻底感染控制的外科手术数量增加
      • 政府机构越来越多地参与
    • 制约因素和问题
      • 成本高
  • 杵分析
  • 感染控制行业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球感染控制市场（按类型）

  • 主要发现
  • 简介
  • 设备
  • 服务
  • 消耗品
  • 其他

第 6 章全球感染控制市场（按最终用途）

  • 主要发现
  • 简介
  • 医院
  • 医疗器械公司
  • 临床实验室
  • 医药研究院
  • 其他

第 7 章全球感染控制市场：按地区

  • 主要发现
  • 简介
    • 2019-2032 年按地区划分的感染控制市场评估
  • 感染控制市场 - 北美
    • 北美：感染控制市场，按最终用途，2019-2032 年
    • 北美：感染控制市场（按类型），2019-2032 年
    • 感染控制市场 - 美国
    • 感染控制市场 - 加拿大
  • 感染控制市场 - 欧洲
    • 欧洲：感染控制市场（按最终用途），2019-2032 年
    • 欧洲：感染控制市场（按类型），2019-2032 年
    • 感染控制市场 - 英国
    • 感染控制市场 - 法国
    • 感染控制市场 - 德国
    • 感染控制市场 - 意大利
    • 感染控制市场 - 西班牙
    • 感染控制市场 - 荷兰
    • 感染控制市场 - 俄罗斯
  • 感染控制市场 - 亚太地区
    • 亚太地区：按最终用途划分的传染病控制市场，2019-2032 年
    • 亚太地区：感染控制市场（按类型），2019-2032 年
    • 感染控制市场 - 中国
    • 感染控制市场 - 印度
    • 感染控制市场 - 马来西亚
    • 感染控制市场 - 日本
    • 感染控制市场 - 印度尼西亚
    • 感染控制市场 - 韩国
  • 感染控制市场 - 中东和非洲
    • 中东和非洲：按最终用途划分的传染病控制市场，2019-2032 年
    • 中东和非洲：感染控制市场（按类型），2019-2032 年
    • 感染控制市场 - 沙特阿拉伯
    • 感染控制市场 - 阿拉伯联合酋长国
    • 感染控制市场 - 以色列
    • 感染控制市场 - 南非
  • 感染控制市场 - 拉丁美洲
    • 拉丁美洲：传染病控制市场，按最终用途，2019-2032 年
    • 拉丁美洲：感染控制市场（按类型），2019-2032 年
    • 感染控制市场 - 墨西哥
    • 感染控制市场 - 巴西
    • 感染控制市场 - 阿根廷

第 8 章竞争格局

  • 扩张和收购分析
    • 扩展名
    • 收购
  • 伙伴关係/协作/协议/披露

第 9 章公司简介

  • 3M Company
  • Belimed AG
  • Halyard Health
  • Getinge Group
  • Matachana Group
Product Code: PM3241

The global infection control market size is expected to reach USD 400.81 billion by 2032, according to a new study by Polaris Market Research. The report "Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type (Equipment, Services, Consumables, Others); End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise in surgical procedures that require rigorous infection control is the main factor driving the market. The positive therapeutic outcomes produced using infection control are regarded to be the cause of the high preference. The COVID-19 pandemic has positively impacted market growth due to the rise in demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device sectors.

According to the WHO's practical advice on the prevention of HAI, the extra amount of time spent in the hospital due to surgical infections was estimated to be around 8 days. These prolonged stays are anticipated to result in a large increase in hospital costs, which heightens the clinical urgency for implementing infection prevention measures. It is anticipated that prolonged hospital stays are not cost-effective for hospitals and healthcare payers as a result of the excessive use of resources to treat the acquired infection.

The market for infection control on a global scale is competitive and only somewhat fragmented. Industry participants are focusing on new product releases, product developments, and global growth in order to improve their market share. Some of the key players in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.

Diseases include pneumonia, infections of the bloodstream, urinary tract, surgical site, and MRSA are the main causes of hospital-acquired infections. Other prominent hospital-acquired infections (HAI) include catheter-related bloodstreams, catheter-associated urinary tract infections, and pneumonia related to ventilators. HAI is one of the major problems that hinders patient recovery and significantly affects death rates globally.

Infection Control Market Report Highlights

Hospitals held the biggest revenue share in 2022 and are projected to grow at the fastest rate (CAGR) throughout the course of the forecast period. The significant portion of infections is primarily due to the high risk of contracting diseases on hospital property through respiratory or bloodborne pathogen transmission.

North America led the industry share in 2022. The increased market share that this sector has managed to capture is regarded to be a result of a consistent number of strategic partnerships taken up by major market participants to increase their product offering and infection control capabilities. The greater efforts made by existing companies to establish themselves throughout this region are also to blame for North America's dominant market share.

3M Corporation, Belimed AG, Halyard Health, Getinge Group, Matachana Group, and others are some of the leading companies competing in the international market.

Polaris Market Research has segmented the Infection Control Market report based on type, end-use, and region:

Infection Control Market, Type (Revenue - USD Billion, 2019 - 2032)

  • Equipment
  • Services
  • Consumables
  • Others

Infection Control Market, End Use (Revenue - USD Billion, 2019 - 2032)

  • Hospital
  • Medical Device Company
  • Pharmaceutical Laboratories

Infection Control Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Infection Control Market Insights

  • 4.1. Infection Control Market - Industry Snapshot
  • 4.2. Infection Control Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase of surgical procedures that demand intensive infection control
      • 4.2.1.2. Rising involvement of government agencies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Infection Control Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Infection Control Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Infection Control, by Type, 2019-2032 (USD Billion)
  • 5.3. Equipment
    • 5.3.1. Global Infection Control Market, by Equipment, by Region, 2019-2032 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global Infection Control Market, by Services, by Region, 2019-2032 (USD Billion)
  • 5.5. Consumables
    • 5.5.1. Global Infection Control Market, by Consumables, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Infection Control Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Infection Control Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 6.4. Medical Device Companies
    • 6.4.1. Global Infection Control Market, by Medical Device Companies, by Region, 2019-2032 (USD Billion)
  • 6.5. Clinical Laboratories
    • 6.5.1. Global Infection Control Market, by Clinical Laboratories, by Region, 2019-2032 (USD Billion)
  • 6.6. Pharmaceutical Laboratories
    • 6.6.1. Global Infection Control Market, by Pharmaceutical Laboratories, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Infection Control Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Infection Control Market - North America
    • 7.3.1. North America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Infection Control Market - U.S.
      • 7.3.3.1. U.S.: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Infection Control Market - Canada
      • 7.3.4.1. Canada: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Infection Control Market - Europe
    • 7.4.1. Europe: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Infection Control Market - UK
      • 7.4.3.1. UK: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Infection Control Market - France
      • 7.4.4.1. France: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Infection Control Market - Germany
      • 7.4.5.1. Germany: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Infection Control Market - Italy
      • 7.4.6.1. Italy: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Infection Control Market - Spain
      • 7.4.7.1. Spain: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Infection Control Market - Netherlands
      • 7.4.8.1. Netherlands: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Infection Control Market - Russia
      • 7.4.9.1. Russia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Infection Control Market - Asia Pacific
    • 7.5.1. Asia Pacific: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Infection Control Market - China
      • 7.5.3.1. China: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Infection Control Market - India
      • 7.5.4.1. India: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Infection Control Market - Malaysia
      • 7.5.5.1. Malaysia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Infection Control Market - Japan
      • 7.5.6.1. Japan: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Infection Control Market - Indonesia
      • 7.5.7.1. Indonesia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Infection Control Market - South Korea
      • 7.5.8.1. South Korea: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Infection Control Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Infection Control Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Infection Control Market - UAE
      • 7.6.4.1. UAE: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Infection Control Market - Israel
      • 7.6.5.1. Israel: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Infection Control Market - South Africa
      • 7.6.6.1. South Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Infection Control Market - Latin America
    • 7.7.1. Latin America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Infection Control Market - Mexico
      • 7.7.3.1. Mexico: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Infection Control Market - Brazil
      • 7.7.4.1. Brazil: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Infection Control Market - Argentina
      • 7.7.5.1. Argentina: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Infection Control Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. 3M Company
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Belimed AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Halyard Health
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Getinge Group
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Matachana Group
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development

List of Tables

  • Table 1 Global Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 2 Global Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 5 North America: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 13 UK: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 France: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 China: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 31 India: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Infection Control Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Infection Control Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End-Use
  • Figure 7 Global Infection Control Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Infection Control Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Infection Control Market